🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📢New from the #WTDay22 Steering Committee in JTH: Awareness of VTE among Patients with Cancer: Preliminary Findings from a Global Initiative for #WorldThrombosisDay Professor Beverley Hunt OBE (also on BlueSky) onlinelibrary.wiley.com/doi/10.1111/jt…

Awareness of VTE among Pts with Cancer: a Global Survey for World Thrombosis Day - 460 cancer pts in 270 countries Shockingly > 2/3s had NO education at all about their risk or signs or symptoms of VTE We need to change this! ⁦World Thrombosis Day⁩ pubmed.ncbi.nlm.nih.gov/36201366/

Cihan Ay Professor Beverley Hunt OBE (also on BlueSky) Marcello Di Nisio @stebarco Mahé Isabelle Gabriela Cesarman PantepAngchaisuksiri Avi Leader Helen Marc Carrier @connors_md @itfarmakis Claire McLintock Fionnuala Ní Áinle George Giannakoulas CECILIA GUILLERMO Luis Jara-Palomares Tzu-Fei Wang Cary Clark It has really been and will be a team work! We all are extremely thankful to every single person who responded and will respond to the survey, and to all who made this initiative possible

Anna Falanga Marcello Di Nisio @GrigorisGerotz1 Luis Jara-Palomares Kostas Syrigos @AnnieYoung3674 Cihan Ay Mario Mandala Annals of Oncology

Apixaban #thromboprophylaxis in ambulatory patients with #cancer and #obesity: Insights from the #AVERT trial Marc Carrier PhilWellsMD Tzu-Fei Wang Aurélien Delluc Vicky Tagalakis Marcello Di Nisio Sudeep Shivakumar #MedTwitter #cvCoag #vte authors.elsevier.com/a/1g~-F_17tKUx…| Thrombosis Research

Hot off the press JACC Journals 🔥Inflammasome Signaling, Thromboinflammation, and Venous Thromboembolism🫁🦵 jacc.org/doi/10.1016/j.… #CardioTwitter #ACC #cvCoag #inflammation #thrombosis

For an upcoming talk, I collated covers of all Phd theses that were finished by "my" PhD students. Humbled by the number, quality, and joy this still brings. Proud that so many continued to work in #thrombosis, clinically, scientifically, or both! #20years

👉European Society of Cardiology Journals. NLRP3 inflammasome and IL-1 contributions to COVID-19-associated coagulopathy and immunothrombosis 🦠🌪️🩸 academic.oup.com/cardiovascres/… #CardioTwitter #CVD #CvCoag #Inflammation #thrombosis #Covid_19 #LongCovid

#APICAT Study: Recruitment completed! Congratulations to European and Canadian centres : 1767 patients enrolled. Extended #anticoagulant #thrombosis in #cancer patients. INNOVTE Assistance Publique – Hôpitaux de Paris (AP-HP) AFSOS ISTH @GroupeUnicancer Dr Jean Pierre Laroche #vacciné 6.0 SFMV

Looking forward to working with you all! Thank you to all our steering committee members, past and present. The WTD campaign is a hallmark of international collaborations and partnerships!

Is FXI inhibition the future of the management of cancer-associated thrombosis? Dr. Marcello Di Nisio provided an elegant review ICTHIC Potentially low risk of bleeding, less drug-drug interactions, less dependence on renal/liver for elimination. Phase 3 trials on-going! Stay

The passing of a giant in the field of cardiovascular medicine: Dr Stuart Connolly passed today. Our thoughts to his family arbormemorial.ca/en/dbburlingto…

Informative post-hoc analysis of the RIDTS study reported by Nicola Potere identified risk factors for recur VTE after stopping AC for distal DVT: unprovoked, shorter AC duration, and diabetes.

Low dose colchicine could target inflammation in VTE, reduce PTS without increasing bleeding🩸! Stay tune for the CONQUEROR DVT pilot trial (double blind, placebo controlled RTC in pts with first LE proximal DVT) proposed by Nicola Potere Marc Carrier #ISTH2024

Kicking off #WorldThrombosisDay in Pescara, 🇮🇹! Come visit us! #StopTheClot #WTDay24 Marcello Di Nisio Matteo Candeloro Ud'A World Thrombosis Day

Great fun today at World Thrombosis Day in Chieti-Pescara 🇮🇹 with colleagues and friends!

A huge THANK YOU to Ud'A for raising awareness about #BloodClots in the beautiful city of Chieti, Italy!❤️ But wait—look who’s there making an impact in person... our very own Steering Committee member Marcello DiNisio! 👏💥

Interesting results with abelacimab in patients with AF NEJM 👇 Can uncoupling hemostasis and thrombosis by blocking FXI also help address unmet need in cancer-associated thrombosis? Can't wait for the results of the ASTER and MAGNOLIA trials! nejm.org/doi/full/10.10… @Anthos_Tx

#BloodClotAwareness Month is here 🩸! Throughout March, ISTH is offering FREE access to ISTH Academy's specialized educational resources on thrombosis in pediatrics, nephrology, women's health, and cancer. 👉🏻Take a look today! bit.ly/43cEE9V #WTDay25 #ISTH

In cancer patients on anticoagulants for ≥6 months: 🔹Reduced-dose #apixaban was non-inferior to full-dose for preventing recurrent #VTE 🔹Reduced dose resulted in fewer clinically relevant bleeding #ACC25 #JACCJournals #CardioOnc #cvCoah Mahé Isabelle